Labeler
Novartis Pharmaceuticals Corporation NDC Codes
Novartis Pharmaceuticals Corporation lists 165 finished drug products in the FDA NDC Directory under NDC labeler code 0078.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Entresto, Promacta, Jadenu, Exforge HCT, Vijoice, Cosentyx, Afinitor, Zortress, Tafinlar, Mekinist, Scemblix, Piqray, Mayzent, Kisqali, Sandostatin LAR Depot
- Active ingredients
- Valsartan, Everolimus, Sacubitril, Eltrombopag olamine, Deferasirox, Amlodipine besylate, Alpelisib, Hydrochlorothiazide, Secukinumab, Dabrafenib mesylate, Trametinib dimethyl sulfoxide, Asciminib hydrochloride
- NDC labeler codes
- 0078
- Strengths (from the 100 most recently listed products)
- Valsartan 160 mg/1; Ribociclib succinate 200 mg/1; Amlodipine besylate 5 mg/1; Hydrochlorothiazide 25 mg/1; Amlodipine besylate 10 mg/1; Alpelisib 50 mg/1; Eltrombopag olamine 12.5 mg/1; Eltrombopag olamine 25 mg/1; Deferasirox 180 mg/1; Deferasirox 360 mg/1; Deferasirox 90 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Imatinib mesylate 400 mg/1; Everolimus 5 mg/1; Hydrochlorothiazide 12.5 mg/1; Remibrutinib 25 mg/1; Atrasentan hydrochloride .75 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Kit, Injection, Solution, Injection, Granule, Tablet, For suspension, Injection, Suspension, Patch, Extended release, Pellet, Injection, Powder, Lyophilized, For solution, Powder, For suspension, Injection, Solution, Concentrate, Powder, For solution, Capsule, Liquid filled, Solution/ drops, Suspension/ drops
- Routes
- Oral, Intravenous, Subcutaneous, Ophthalmic, Transdermal, Intravitreal
- Drug classes (FDA established)
- Kinase Inhibitor, Angiotensin 2 Receptor Blocker, mTOR Inhibitor Immunosuppressant, Neprilysin Inhibitor, Thrombopoietin Receptor Agonist, Iron Chelator, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Sphingosine 1-phosphate Receptor Modulator, Thiazide Diuretic, Interleukin-17A Antagonist, Cholinesterase Inhibitor, CD19-directed Chimeric Antigen Receptor, Genetically-modified Autologous T Cells, Antimalarial, Endothelin Receptor Antagonist, Corticosteroid, Complement Factor B Inhibitor, Radioligand Therapeutic Agent, Selectin Blocker, Anthelmintic, Topoisomerase Inhibitor, Nucleoside Metabolic Inhibitor, Lymphocyte Function-Associated Antigen-1 Antagonist, Nonsteroidal Anti-inflammatory Drug, CD20-directed Cytolytic Antibody
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Votrientpazopanib hydrochloride | Pazopanib hydrochloride 200 mg/1 | Tablet, Film coatedOral | 0078-1077 | 00078-1077-66 | — |
| Xiidralifitegrast | Lifitegrast 50 mg/mL | Solution/ dropsOphthalmic | 0078-0911 | 00078-0911-1200078-0911-94 | — |
| Promactaeltrombopag olamine | Eltrombopag olamine 25 mg/1 | Tablet, Film coatedOral | 0078-0685 | 00078-0685-15 | — |
| Tafinlardabrafenib | Dabrafenib mesylate 50 mg/1 | CapsuleOral | 0078-0682 | 00078-0682-66 | — |
| Promactaeltrombopag olamine | Eltrombopag olamine 50 mg/1 | Tablet, Film coatedOral | 0078-0686 | 00078-0686-1500078-0686-55 | — |
| Tafinlardabrafenib | Dabrafenib mesylate 75 mg/1 | CapsuleOral | 0078-0681 | 00078-0681-66 | — |
| Promactaeltrombopag olamine | Eltrombopag olamine 75 mg/1 | Tablet, Film coatedOral | 0078-0687 | 00078-0687-15 | — |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide .5 mg/1 | Tablet, Film coatedOral | 0078-1105 | 00078-1105-15 | — |
| Mekinisttrametinib | Trametinib dimethyl sulfoxide 2 mg/1 | Tablet, Film coatedOral | 0078-1112 | 00078-1112-1500078-1112-94 | — |
| Entrestosacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | 0078-0659 | 00078-0659-2000078-0659-67 | — |
| Entrestosacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | 0078-0777 | 00078-0777-2000078-0777-67 | — |
| Entrestosacubitril and valsartan | Sacubitril 24 mg/1; Valsartan 26 mg/1 | Tablet, Film coatedOral | 0078-9659 | 00078-9659-50 | — |
| Entrestosacubitril and valsartan | Sacubitril 49 mg/1; Valsartan 51 mg/1 | Tablet, Film coatedOral | 0078-9777 | 00078-9777-50 | — |
| Entrestosacubitril and valsartan | Sacubitril 97 mg/1; Valsartan 103 mg/1 | Tablet, Film coatedOral | 0078-0696 | 00078-0696-2000078-0696-67 | — |
| Jadenudeferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | 0078-0656 | 00078-0656-15 | — |
| Jadenudeferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | 0078-0654 | 00078-0654-15 | — |
| Jadenudeferasirox | Deferasirox 180 mg/1 | Tablet, Film coatedOral | 0078-0655 | 00078-0655-15 | — |
| Cosentyxsecukinumab | Secukinumab 75 mg/.5mL | InjectionSubcutaneous | 0078-1056 | 00078-1056-9700078-1056-99 | — |
| Cosentyxsecukinumab | Secukinumab 300 mg/2mL | InjectionSubcutaneous | 0078-1070 | 00078-1070-6800078-1070-96 | — |
| Cosentyxsecukinumab | Secukinumab 150 mg/mL | InjectionSubcutaneous | 0078-0639 | 00078-0639-4100078-0639-6800078-0639-97+1 more | — |
| Gleevecimatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | 0078-1490 | 00078-1490-13 | — |
| Gleevecimatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | 0078-0649 | 00078-0649-1300078-0649-30 | — |
| Ilevronepafenac | Nepafenac 3 mg/mL | Suspension/ dropsOphthalmic | 0078-0743 | — | — |
| Afinitor Disperzeverolimus | Everolimus 2 mg/1 | Tablet, For suspensionOral | 0078-0626 | 00078-0626-51 | — |
| Afinitor Disperzeverolimus | Everolimus 3 mg/1 | Tablet, For suspensionOral | 0078-0627 | 00078-0627-51 | — |
| Afinitor Disperzeverolimus | Everolimus 5 mg/1 | Tablet, For suspensionOral | 0078-0628 | 00078-0628-51 | — |
| Afinitoreverolimus | Everolimus 7.5 mg/1 | TabletOral | 0078-0620 | 00078-0620-51 | — |
| Gilenyafingolimod hcl | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | 0078-0607 | 00078-0607-15 | — |
| Gilenyafingolimod hcl | Fingolimod hydrochloride .25 mg/1 | CapsuleOral | 0078-0965 | 00078-0965-89 | — |
| Afinitoreverolimus | Everolimus 2.5 mg/1 | TabletOral | 0078-0594 | 00078-0594-51 | — |
| Zortresseverolimus | Everolimus 1 mg/1 | TabletOral | 0078-0422 | 00078-0422-20 | — |
| Zortresseverolimus | Everolimus .75 mg/1 | TabletOral | 0078-0415 | 00078-0415-20 | — |
| Zortresseverolimus | Everolimus .25 mg/1 | TabletOral | 0078-0417 | 00078-0417-20 | — |
| Zortresseverolimus | Everolimus .5 mg/1 | TabletOral | 0078-0414 | 00078-0414-20 | — |
| Kesimptaofatumumab | Ofatumumab 20 mg/.4mL | Injection, SolutionSubcutaneous | 0078-1007 | 00078-1007-6800078-1007-98 | — |
| Coartemartemether and lumefantrine | Artemether 20 mg/1; Lumefantrine 120 mg/1 | TabletOral | 0078-0568 | 00078-0568-45 | — |
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 5 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0078-0560 | 00078-0560-15 | — |
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 5 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0078-0559 | 00078-0559-15 | — |
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 10 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0078-0561 | 00078-0561-15 | — |
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 10 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0078-0562 | 00078-0562-15 | — |
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 10 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0078-0563 | 00078-0563-15 | — |
| Afinitoreverolimus | Everolimus 5 mg/1 | TabletOral | 0078-0566 | 00078-0566-51 | — |
| Afinitoreverolimus | Everolimus 10 mg/1 | TabletOral | 0078-0567 | 00078-0567-51 | — |
| Tasignanilotinib | Nilotinib hydrochloride monohydrate 200 mg/1 | CapsuleOral | 0078-0526 | 00078-0526-5100078-0526-87 | — |
| Tasignanilotinib | Nilotinib hydrochloride monohydrate 150 mg/1 | CapsuleOral | 0078-0592 | 00078-0592-5100078-0592-87 | — |
| Tasignanilotinib | Nilotinib hydrochloride monohydrate 50 mg/1 | CapsuleOral | 0078-0951 | 00078-0951-66 | — |
| Exelonrivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | 0078-0501 | 00078-0501-15 | — |
| Exelonrivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | 0078-0502 | 00078-0502-15 | — |
| Exelonrivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | 0078-0503 | 00078-0503-15 | — |
| Exforgeamlodipine besylate and valsartan | Amlodipine besylate 5 mg/1; Valsartan 160 mg/1 | Tablet, Film coatedOral | 0078-0488 | 00078-0488-15 | — |
Novartis Pharmaceuticals Corporation: common questions
- What is Novartis Pharmaceuticals Corporation's NDC labeler code?
- 0078. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Novartis Pharmaceuticals Corporation?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.